The DFS of breast cancer patients with PIK3CA exon 20 mutation, exon 9 mutation, and wild-type were 22.5-months, 32-months and 24-months, respectively, but the difference was not statistically significant (χ2 = 0.347, p = 0.982, Fig. 7). Here, PIK3CA is linked to breast carcinoma.